![]() Dermavant Sciences Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology. | ![]() Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
| ![]() scPharmaceuticals scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery. | |
Founding Date | Founding Date 2016 | Founding Date 2006 | Founding Date 2014 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Long Beach, US HQ Basel, CH Durham, US Morrisville, US New York, US Phoenix, US | Locations San Diego, US HQ San Diego, US | Locations Burlington, US HQ |
Employees | Employees 2228% decrease | Employees 31019% decrease | Employees 96256% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.5 m | Valuation ($) 221.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $62.8m (FY, 2022) | Revenue (est.) $36.3m (FY, 2024) |
Net income | Net income ($255.3m) (FY, 2019) | Net income ($577.8m) (FY, 2022) | Net income ($85.1m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 200m | Total funding raised $ 42.6m | Total funding raised $ 62.5m |

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
View company
scPharmaceuticals, a biopharmaceutical company, develops a portfolio of transformative pharmaceutical products for subcutaneous delivery.
View company